{"name":"Nitric Oxide Innovations LLC","slug":"nitric-oxide-innovations-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPV2hjcUJRVWJNSnJsTjJlTnd3UkhfNU1MNlZyVjNHcFlSWlV6bnZmbDRWR1NGRHFYdEl5aFJxQXRiRUdadUpHQldIT0lLYVNSdDlmZU9KVFlscTd0NkNKamc4SzFzSmNrZm1aMDB3T3RYSVk2Uy1WYlprWEQ2c1lsd0RUVHdwOGF2cVo4Smt3MThrLXdiOUNnVEluY2hlYnJLTlQwMEpPOFJkYmV6dnliS0JBU2wxZW1XbHp2dmNRN1pKbE5BRnJJOUtsMEdUUEd1ZTVwMzdYNXI?oc=5","date":"2025-04-23","type":"pipeline","source":"respiratory-therapy.com","summary":"Innovations in Inhaled Nitric Oxide Delivery - respiratory-therapy.com","headline":"Innovations in Inhaled Nitric Oxide Delivery - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOdVdwT1MtSERNWF9zTGx4WHktcFBMV2RhOTloSkZrbTlzYU1OS1lVT0tvVTZ0cC0weXJQWFdxOTJ6Q2k1RENGZ200ZkJvMWtWTHB6WlFLbndRQjd1RDBRYlh0Rmp4LWNHVl9Eb2pxOWFWQ0g3cjBNaExYZ2h3aHdpSVpYRE1pOU5kcHplSnIzeFk0LWo1aFJVSzdtdEQ2Y3JiR1FGdG0xY0pJV1pva051cmNXSk00M0VJbzJsTUpB?oc=5","date":"2023-11-09","type":"regulatory","source":"respiratory-therapy.com","summary":"Genosyl Inhaled Nitric Oxide Delivery System Approved by FDA - respiratory-therapy.com","headline":"Genosyl Inhaled Nitric Oxide Delivery System Approved by FDA - respiratory","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNMnNRUHoxUnc4eUg2LTMxSjUwOTh2dE5EYkRNUjRfQkNnOXdfUnJmVzF1WHc0QU85U21mXzNLalJoaFhVWjFzV0tOSFdKQ2JaU0NoRVdEVE42NElDWEhUcWg0RXN3MGczWUpNcGJ1MXY3SWd6RDdBYVh3N2ZhaV9odVhjbzRoRGFaUE9CMktRTzNZS1FLZmZBZkVkc0ctcEdCaEVScm1kQ0xrOF9Bc2dQaFJJTTJ1OGZVWmJORWVSNzV6aXRoSGNwWkNsOVdES3dJVGc4Zm0xOTBZYldabllITE54WDNYQWNHcU14ck4yaFFrcy16UnhkSHpORzZMV0MxUmt3am92eV9XbV9IQzlR?oc=5","date":"2023-01-11","type":"pipeline","source":"PR Newswire","summary":"VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System - PR Newswire","headline":"VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxOYzVrdWRWdHdTTHZzMHhGUnl2aklzZ1VuOWFJQVpyeXdXcl9DT2I4ZHYxRnR4ZzlPc25aY3VieExfd2ZnbUNIMExVRTJac0xRNjhQU0tTWlhBQi1QQmpLcndBazljUHU5bTkxZ05uUFcxZUpuanNuaXJaOEtNOHRXaXJubG5Db2poY3U2NmRLcDQzb0dLVTJEcTVEWjU4Z1JMT2JKRmJHUGRNX1NyN04tclE3eVRjeFhDNm5HcV9YZTNSUXVUeUo1MDlhZ2sxM1cwbTJKN0psdTlzSkZlcDJQR25ELU93UG9oNWxBVWVOZG85QWxTNlFSY2QyME10XzRrVThtQjkwWHAyTGYtclBkZEdTMDQwV1RMekpmWjhNQjdjaEc0RDQ5dkg5UURJQko4ODVocGpiNmdNMzNneGIxOVVxMmJqaFlMd1dHNWVrbV8xdVc1QWRWS1JQSGhmZWN6OVQw?oc=5","date":"2022-09-15","type":"pipeline","source":"GlobeNewswire","summary":"Nathan S. Bryan, Ph.D Book, \"The Secret Of Nitric Oxide - - GlobeNewswire","headline":"Nathan S. Bryan, Ph.D Book, \"The Secret Of Nitric Oxide -","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZ3RDSlg2NW9XUkd5cEdGeXZia09WZzVGVlg5U2J4cVpRbXlGLXVJZTZ4TTNCUFR1MjNmY3lLSk82UU56bzNiREVJYnRDUDhHWTVRcGtjSlNBLVJ2a2lJQTVOcTFRaW8wSjhQWWZVY0k1Z0l1OE5FUGx0TEV3dmw0Q2xXMXczN1FMNlhr?oc=5","date":"2021-06-16","type":"deal","source":"Yahoo Finance","summary":"Nitric Oxide Innovations Drug Company Founder and CEO, Nathan Bryan Ph.D, Engages Alan Morell, Creative Management Partners (CMP), as Senior Advisor for Worldwide Licensing, Media Positioning Represen","headline":"Nitric Oxide Innovations Drug Company Founder and CEO, Nathan Bryan Ph.D, Engages Alan Morell, Creative Management Partn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5PeUR6WE9vN3Q5UkdhMWVFMnY2MVU2WF9Gcy1QUXFaNkNFVWVfR3ZUSlZRM3JpcndYZm9ybkE5M016aVVlU2t6eDhqeGpBb2lXdzR3?oc=5","date":"2020-10-26","type":"trial","source":"FirstWord Pharma","summary":"Clinical Study Begins for the First Oral Systemic Nitric Oxide Based Therapeutic for African Americans with COVID-19 - FirstWord Pharma","headline":"Clinical Study Begins for the First Oral Systemic Nitric Oxide Based Therapeutic for African Americans with COVID-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxQeDY0QUdrMmhXQnVTYnozR0VaR0M5TEhCZjRTa2YxdzRsdlIxUTRpVW11VGlXMF9CaEdVandLZGpfUXlnZWc3bHUxbUFCUUFXWlZMOWo0d3pUTEd6OEw2TVBZTTE2Y2xkR1dIMXlGTE0xSkJoYVZwSDJ1Nk9qODJZRWkzVFZnTkFVRER3ZUQ4U3ZKOUUtU0FTcjkzRGplVHdZekg5ajE3SWsyTEhlZTFMV2E2ZWpvMXhKT2h1Y19SandWdFBmYUVsWDZRbXNhV21vM0o4SzgxR3prdzU3b0RJeVpVSWZpNlltdUNiZ2dhdS1Ma2ZweDc4WE1jRm1pS0k4eE51QVdwNi16Mm9QRXdNRndEWVpfa0FyVzcxc1ZQYi1zRHc2M0pCQk9LdVpiZl9vRjRlOFUwWlZMN0pxR1dmaU9UdGFPMTN3d1ZxMTg1dm9KVWt0ZE5rX0l0dw?oc=5","date":"2020-04-01","type":"trial","source":"PR Newswire","summary":"Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection and Associated Lung Complications - PR Newswire","headline":"Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOTXo4amNCQWRCZTBkUWdTQWQ5ZThZRGd3QTI5aGlzU0otZ0xlNWdrVU1EQWk5RktiTVhoNzM0TWVqUS1iZnAwaWJwTkVpNTFaejlfeXBQaXVKWHJ2Wkt1cW13b01CSC0yZkdFcEYtTTRJT3FLMjEtb3dCYVFTYVc1NlZfeUNWZWFTYzJHbmdFeExSeG5jTHpmZE4xLXFOZG1rMGVvU3BBX1JSWmVrUzhJbGpR?oc=5","date":"2014-08-19","type":"pipeline","source":"Pulmonary Hypertension News","summary":"GeNo LLC | Novel Nitric Oxide Delivery System May Someday Improve PH Treatments - Pulmonary Hypertension News","headline":"GeNo LLC | Novel Nitric Oxide Delivery System May Someday Improve PH Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPNVgzbnJfSU5XREdENUdFMXp4SWVNeF9pbldudkFXUTJweVdnaDNDTC1KTmltcDYtUGE3WEM5alFmcFZNNFg2Vng4V05hZGctOWpuWmNVa3RzWXFrSy1xSWMxVnNoNTNFX3VaTGNXcERKZ1pGSU5tRVRQcnNsZE9rLW4xUTZBaWpRVUxXd3NlSnhDeFZCMGhSWFh6SnVjMWdGeFE0S0h2SC16MER0UGJqQjJCOUhxeFlqcnQ5TS1IMFJleUtpOXVoMnM0U1h6NGh0Um9oX3htbVYzeTdSLXczYUh2UmMxQjc3c0cyUks3cnhkTDlpRmxrbW5CcEZ1NmR6NUZrVUxhbkRHNHpyZ05hQmdRd1VvTWVIOUJLU0xzYks5c0M1dGd2cmJqRndCYlNKamdJ?oc=5","date":"2013-10-09","type":"pipeline","source":"PR Newswire","summary":"Novoteris, LLC., Medical Device and Pharmaceutical Product Innovators, Receives Orphan Drug Designation for Nitric Oxide for the Treatment of Cystic Fibrosis - PR Newswire","headline":"Novoteris, LLC., Medical Device and Pharmaceutical Product Innovators, Receives Orphan Drug Designation for Nitric Oxide","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}